Cenobamate beyond Epilepsy: exploring associations with vascular risk factors through serological markers

Key Points

• Cenobamate may influence vascular risk factors linked to clinical outcomes, indicating its wider therapeutic role.
• The primary outcome demonstrated a significant relationship between serological markers and vascular health in those using cenobamate.
• Observational analysis of clinical data explores the connection between cenobamate treatment and serological biomarkers.
• Findings highlight potential cardiovascular concerns, calling for additional studies to confirm these associations with vascular risk factors.